Acetyl hexapeptide-3
Also known as: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2, Ac-HEX-3, Ac-hexapeptide-3, Acetyl hexapeptide-8, Acetyl Hexapeptide‑3, Acetyl‑hexapeptide‑3, AH3, Argireline
Source Acetyl hexapeptide-3 at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Acetyl hexapeptide-3 (also known as Argireline) is a synthetic cosmetic peptide applied topically to the skin. It is marketed for its anti‑wrinkle and skin‑rejuvenating properties, aiming to improve hydration, reduce transepidermal water loss, and stimulate collagen production.
Mechanism of Action
Acetyl hexapeptide-3 is a short neuropeptide that interferes with the release of acetylcholine from peripheral nerve endings, thereby diminishing muscle‑contractile signals that contribute to wrinkle formation. In skin models it also up‑regulates the antioxidant enzyme SOD2 and promotes type I collagen synthesis, likely through indirect activation of fibroblasts. These actions together support a smoother, more hydrated epidermis.
What the Research Shows
In vitro and ex vivo work using a sensory‑neuron‑integrated skin spheroid model (2025) showed that the peptide penetrates the stratum corneum, accumulates near sensory neurons, suppresses acetylcholine release, raises SOD2 levels and boosts collagen I. A 2021 fibroblast study found that, when combined with other cosmeceutical peptides, acetyl hexapeptide‑3 enhanced catecholamine‑related activity and contributed to higher hydroxyproline, elastin and antioxidant enzyme activities. A small randomized controlled trial (2017) demonstrated measurable reductions in wrinkle‑related topography parameters and transepidermal water loss after 60 days of topical use. Delivery challenges due to hydrophilicity have been addressed in 2020–2021 microneedle research, which reported successful incorporation of the peptide into 3‑D‑printed microneedle patches and improved transdermal permeation without cytotoxicity.
Reported Benefits
Clinical data suggest modest anti‑wrinkle effects and decreased skin water loss. Laboratory studies report increased collagen and elastin synthesis, enhanced antioxidant enzyme activity, and improved skin hydration. When formulated with other peptides, it may contribute to broader anti‑aging benefits, and microneedle delivery systems appear to increase its skin penetration.
Limitations of the Evidence
Human evidence is limited to a single small RCT; most data are from cell cultures, skin spheroids or ex vivo skin. Long‑term efficacy and safety have not been established. The peptide’s large, hydrophilic nature hampers passive skin permeation, requiring specialized delivery approaches that are still experimental. The precise molecular pathways beyond acetylcholine inhibition remain incompletely defined.
Safety Considerations
Across the reported studies acetyl hexapeptide‑3 exhibited minimal cytotoxicity to human dermal fibroblasts and no adverse skin reactions were noted in the short‑term human trial. However, safety data are confined to limited‑duration, small‑scale investigations, so broader tolerability and rare adverse effects have not been fully characterised.
How It Is Administered
The peptide is intended for topical application, typically incorporated into creams, serums or film‑based formulations. Experimental delivery includes 3‑D‑printed microneedle patches designed to breach the stratum corneum and deposit the peptide into deeper layers. Formulations are generally aqueous‑based to accommodate its hydrophilic nature.
Routes of Administration
Goals & Uses
- Skin tighteningCosmeticLow
- Skin texture improvementAesthetics / Anti AgingLow
- Reduction of facial expression wrinklesAesthetics / Anti AgingModerate
- wrinkle reductionCosmeticLow
- Non-invasive alternative to botulinum toxinAestheticsLow
Contraindications
- Application to broken or irritated skinDermatologicalModerate
- known hypersensitivity to peptideImmunologicModerate
- Known hypersensitivity to peptide componentsAllergyHigh
Adverse Effects
- Contact dermatitisDermatologicalRare
- Tingling or stinging sensationDermatologicalUncommon
- Skin irritation / erythemaDermatologicalUncommon
- Skin irritationDermatologicUncommon
Drug Interactions
- Botulinum toxin injections (topical co-use)Low
Population Constraints
- PregnancyReproductive SafetyRelative
- Infants and young childrenPediatricRelative
- Pregnant or lactating womenReproductiveRelative
Regulatory Status
- European UnionUnapprovedRegulated under cosmetic regulations, not a medicinal product.
- United StatesUnapprovedClassed as a cosmetic ingredient, not evaluated by FDA as a drug.
- United KingdomApprovedApproved: Cosmetic ingredient for topical anti-aging productsRegulated under UK cosmetics regulation post-Brexit; permitted as cosmetic ingredient.
Regulated as a cosmetic ingredient in the US (FDA), EU (ECHA/SCCS), and UK. Not classified as a drug. No therapeutic claims are permitted. Listed as safe for cosmetic use at concentrations typically up to 10%.
Evidence & Sources
- Journal ArticleLowMartin BA, et al.2025-01-01T00:00:00.000000Z
- Journal ArticleLowWu Y, et al.2021-01-01T00:00:00.000000Z
- Journal ArticleLowLim SH, et al.2021-01-01T00:00:00.000000Z
- Journal ArticleModerateRaikou V, et al.2017-01-01T00:00:00.000000Z
- Journal ArticleLowLim SH, et al.2020-01-01T00:00:00.000000Z
- Journal ArticleModerateWisniewski JD, Ellis DL, Lupo MP2014-01-01T00:00:00.000000Z
Frequently Asked Questions
How does acetyl hexapeptide‑3 differ from botulinum toxin?
Both aim to reduce muscle‑driven wrinkles, but acetyl hexapeptide‑3 works topically by modestly limiting acetylcholine release, whereas botulinum toxin is an injectable neurotoxin that blocks neurotransmission more completely. The peptide offers a non‑invasive alternative with a milder effect.
Can the peptide be used alone or does it need other ingredients?
Studies have tested it both alone and in combination with other cosmeceutical peptides. When combined, synergistic improvements in antioxidant and collagen markers were observed, but single‑product formulations have also shown measurable wrinkle reduction in clinical trials.
Is microneedle delivery necessary for effectiveness?
Because the peptide is hydrophilic and relatively large, passive skin penetration is limited. Microneedle patches have been shown to enhance delivery in vitro, but conventional topical products still demonstrate some biological activity, suggesting microneedles are optional but may improve efficacy.
Are there any known side effects?
Published data report no significant irritation or cytotoxicity in short‑term use. Nonetheless, comprehensive safety assessments are lacking, so users should monitor for any unexpected skin reactions, especially when combined with other active cosmetics.
How long does it take to see results?
In the 2017 randomized trial, measurable improvements in wrinkle topography and water loss were reported after 20 days, with further gains at 60 days. Individual response may vary depending on formulation and delivery method.
What is Acetyl hexapeptide-3?
Acetyl hexapeptide-3 (also known as Argireline) is a synthetic cosmetic peptide applied topically to the skin. It is marketed for its anti‑wrinkle and skin‑rejuvenating properties, aiming to improve hydration, reduce transepidermal water loss, and stimulate collagen production.
What is Acetyl hexapeptide-3 used for?
Acetyl hexapeptide-3 is educationally associated with: Skin tightening, Skin texture improvement, Reduction of facial expression wrinkles, wrinkle reduction, Non-invasive alternative to botulinum toxin. Educational only — not medical advice.
How is Acetyl hexapeptide-3 administered?
Recorded routes of administration: Topical.
What are the potential side effects of Acetyl hexapeptide-3?
Reported adverse effects include: Contact dermatitis, Tingling or stinging sensation, Skin irritation / erythema, Skin irritation. This list is not exhaustive — consult a qualified clinician.
Who should avoid Acetyl hexapeptide-3?
Recorded contraindications: Application to broken or irritated skin, known hypersensitivity to peptide, Known hypersensitivity to peptide components. Consult a qualified clinician before use.